Skip to main content
Top
Published in: Supportive Care in Cancer 2/2016

01-02-2016 | Original Article

Implementation of NCCN Palliative Care Guidelines by member institutions

Authors: Alexandra Albizu-Rivera, Diane G. Portman, Sarah Thirlwell, Shirley N. Codada, Kristine A. Donovan

Published in: Supportive Care in Cancer | Issue 2/2016

Login to get access

Abstract

Increasingly, evidence suggests the integration of palliative care (PC) with standard oncologic care can yield substantial benefits. As part of an effort to improve the PC of cancer patients, the National Comprehensive Cancer Network (NCCN) has developed clinical practice guidelines for PC that promote access to quality, evidence-based PC. This study sought to characterize current implementation of the guidelines by NCCN member institutions. Institutional representatives appointed to the NCCN Palliative Care Guidelines Panel were asked to complete an online survey in the spring of 2014. The survey focused on availability of PC services, screening and referral practices for PC, PC education, and quality improvement programs. The survey was completed by representatives from 21 of 25 NCCN member institutions (84 %). A majority routinely provides PC services via interdisciplinary teams; 52 % routinely inform patients of the availability, elements, and benefits of PC. The guidelines are most often used to guide clinical practice; only 10 % reported using the guidelines to formally screen for PC needs and/or make referrals to PC specialists. Among the 62 % of institutions that screen any patients using any available criteria, when a patient screens positive for PC needs, a referral to a PC specialist is made less than half the time. Implementation of PC Guidelines is incomplete and various aspects of the guidelines, such as the recommendation to screen all patients for PC needs, are applied inconsistently. Despite this, most institutions provide PC services in a manner consistent with the guidelines. Greater implementation of the guidelines’ recommendations is needed.
Literature
1.
go back to reference Smith TJ et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887PubMedCrossRef Smith TJ et al (2012) American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 30:880–887PubMedCrossRef
2.
go back to reference Levy MH (1999) NCCN Task Force reports: supportive and palliative care. Oncology 13:517–522 Levy MH (1999) NCCN Task Force reports: supportive and palliative care. Oncology 13:517–522
3.
go back to reference Network, N.C.C. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines (R)). Palliative Care 2014 [cited August 22, 2014 Network, N.C.C. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines (R)). Palliative Care 2014 [cited August 22, 2014
4.
go back to reference Zafar SY et al (2010) Standards for palliative care delivery in oncology settings. Cancer J 16:436–443PubMedCrossRef Zafar SY et al (2010) Standards for palliative care delivery in oncology settings. Cancer J 16:436–443PubMedCrossRef
5.
go back to reference Hui D et al (2012) The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 43:582–592PubMedCrossRef Hui D et al (2012) The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 43:582–592PubMedCrossRef
7.
8.
go back to reference Glare P et al (2013) Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists. J Natl Compr Cancer Netw 11:1087–96 Glare P et al (2013) Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists. J Natl Compr Cancer Netw 11:1087–96
Metadata
Title
Implementation of NCCN Palliative Care Guidelines by member institutions
Authors
Alexandra Albizu-Rivera
Diane G. Portman
Sarah Thirlwell
Shirley N. Codada
Kristine A. Donovan
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2862-y

Other articles of this Issue 2/2016

Supportive Care in Cancer 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine